test Bank Pharmacology A PatientCentered Nursing Process Approach 10th Edition by McCuistion

Test Bank Pharmacology A Patient-
Centered Nursing Process Approach
10th Edition by McCuistion

,CONTENTS

Section I: Introduction to Pharmacology
ws ws ws ws




1. The Nursing Process and Patient-Centered Care
ws ws ws ws ws




2. Drug Development and Ethical Considerations
ws ws ws ws




3. Pharmacokinetics and Pharmacodynamics ws ws




4. Pharmacogenetics
5. Complementary and Alternative Therapies ws ws ws




6. Pediatric Considerations
ws




7. Older Adult Considerations
ws ws




8. Drugs in Substance Use Disorder
ws ws ws ws




Section II: Pharmacotherapy and Drug Administration
ws ws ws ws ws




9. Safety and Quality
ws ws




10. Drug Administration
ws




11. Drug Calculations
ws




Section III: Maintenance of Homeostasis
ws ws ws ws




12. Fluid Volume and Electrolytes
ws ws ws




13. Vitamin and Mineral Replacement
ws ws ws




14. Nutritional Support ws




Section IV: Autonomic Nervous System Drugs
ws ws ws ws ws




15. Adrenergic Agonists and Antagonists
ws ws ws

,16. Cholinergic Agonists and Antagonists
ws ws ws




Section V: Central and Peripheral Nervous System Drugs
ws ws ws ws ws ws ws




17. Stimulants
18. Depressants
19. Antiseizure Drugs ws




20. Drugs for Parkinsonism and Alzheimer‘s Disease
ws ws ws ws ws




21. Drugs for Neuromuscular Disorders and Muscle Spasms
ws ws ws ws ws ws




Section VI: Mental and Behavioral Health Drugs
ws ws ws ws ws ws




22. Antipsychotics and Anxiolytics ws ws




23. Antidepressants and Mood Stabilizers ws ws ws




Section VII: Pain and Inflammation Management Drugs
ws ws ws ws ws ws




24. Antiinflammatories
25. Analgesics
Section VIII: Antimicrobial Drugs
ws ws ws




26. Antibacterials
1. Section A: Penicillins and Cephalosporins
ws ws ws ws




2. Section B: Macrolides and Tetracyclines
ws ws ws ws




3. Section C: Aminoglycosides and Fluoroquinolones
ws ws ws ws




4. Section D: Sulfonamides and Metronidazole
ws ws ws ws




27. Antituberculars, Antifungals, and Antivirals ws ws ws




28. Antimalarials, Anthelmintics, and Peptides
ws ws ws

, Section IX: Immunologic Drugs
ws ws ws




29. HIV- and AIDS-Related Drugs
ws ws ws




30. Transplant Drugs ws




31. Vaccines
Section X: Antineoplastics and Biologic Response Modifiers
ws ws ws ws ws ws




32. Anticancer Drugs ws




33. Targeted Therapies to Treat Cancer
ws ws ws ws




34. Biologic Response Modifiers
ws ws




Section XI: Respiratory Drugs
ws ws ws




35. Upper Respiratory Disorders
ws ws




36. Lower Respiratory Disorders
ws ws




Section XII: Cardiovascular Drugs
ws ws ws




37. Cardiac Glycosides, Antianginals, and Antidysrhythmics
ws ws ws ws




38. Diuretics
39. Antihypertensives
1. Section A: Beta Blockers
ws ws ws




2. Section B: Alpha Blockers
ws ws ws




3. Section C: Drugs Affecting RAAS
ws ws ws ws




4. Section D: Calcium Channel Blockers
ws ws ws ws




40. Anticoagulants, Antiplatelets, and Thrombolytics
ws ws ws




41. Antihyperlipidemics and Drugs to Improve Peripheral Bloodws ws ws ws ws ws